CAS 100163-29-9: rac-Ethylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconium dichloride
Description:Rac-Ethylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconium dichloride, commonly referred to as rac-Et(Ind)2ZrCl2, is a zirconium-based organometallic compound primarily used as a catalyst in olefin polymerization processes. This compound features a racemic mixture of ethylene-bis(4,5,6,7-tetrahydro-1-indenyl) ligands coordinated to a zirconium center, which is further stabilized by two chloride ions. The unique structure of this compound allows for high activity and selectivity in polymerization reactions, making it valuable in the production of various polyolefins. Its characteristics include a relatively high thermal stability and solubility in non-polar solvents, which facilitates its use in industrial applications. Additionally, the presence of the bulky tetrahydro-1-indenyl groups contributes to its ability to control the stereochemistry of the resulting polymers. Safety precautions should be observed when handling this compound, as it may pose health risks if inhaled or ingested. Overall, rac-Et(Ind)2ZrCl2 is significant in the field of polymer chemistry for its catalytic properties.
Formula:C20H24Cl2Zr
InChI:InChI=1/C20H24.2ClH.Zr/c1-3-7-19-15(5-1)9-11-17(19)13-14-18-12-10-16-6-2-4-8-20(16)18;;;/h9-12H,1-8,13-14H2;2*1H;/q;;;+2/p-2/rC20H24.Cl2Zr/c1-3-7-19-15(5-1)9-11-17(19)13-14-18-12-10-16-6-2-4-8-20(16)18;1-3-2/h9-12H,1-8,13-14H2;

rac-Ethylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconium dichloride
Ref: 08-40-1400
100mg | 161.00 € | ||
500mg | 502.00 € |

Zirconium,dichloro[rel-(7aR,7'aR)-1,2-ethanediylbis[(1,2,3,3a,7a-h)-4,5,6,7-tetrahydro-1H-inden-1-ylidene]]-
Ref: IN-DA00H96B
1g | 528.00 € | ||
100mg | 117.00 € | ||
250mg | 206.00 € |

Dichloro [rac-ethylenebis(4,5,6,7-tetrahydro-1-indenyl)] zirconium(IV)
Ref: 3D-FD34527
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |